Abstract
AbstractThe alkylation of 4‐substituted tetrazolo‐pyridines bearing electron‐withdrawing groups 7a–f to give the expected tetrazolo‐pyridinium salts 7a–f,Me or 7a–f,Et as a mixture of two N3/N2 isomers in good to quantitative yields in toluene, has been investigated. The nature of the alkyl group did not significantly affect the chemical shifts of the salts or the N3/N2 ratio, which was approximately 9:1, except for 7d,Me for which a 1:1 ratio was obtained. The alkylated tetrazolo‐pyridines were shown to react with cyclopentadiene and, in some cases, with 2,3‐dimethylbutadiene and isoprene, whereas the neutral tetrazolo‐pyridines remained unreactive towards dienes, indicating experimentally an increase in the electrophilicity of the heterocycles upon alkylation. TheDiels–Alder adducts were fully characterized through an extensive NMR and crystallographic study. It was found that the tetrazolo‐pyridinium salts either do not react or react very slowly with cyclohexadiene, showing the limitations of the scope of this activation. The theoretical scale of electrophilicity introduced by Domingo et al. on the basis of the global electrophilicity index, ω, defined by Parr, is also a very useful tool to discuss the relative reactivities of the various salts. The ω and ΔN indexes are shown to highlight the electrophilic activation of tetrazolo‐pyridines, 7a,Me and 7b,Me, which have indexes close to those of 4,6‐dinitrotetrazolo‐pyridine, which is one of the most electrophilic neutral heterocycles known to date. Using the known N and s parameters, which characterize the nucleophilicity of nucleophiles, the rate constants were found to fit the three‐parameter equation log k2 = s(N + E) introduced by Mayr to describe the feasibility of nucleophilic–electrophilic combinations. Based on this, the electrophilicity parameter E of 7a–b,Me was determined. With E values around –7, this corresponds to a positioning of the reactivity of the carbocyclic ring of the tetrazolo‐pyridinium salts in a domain of high electrophilicity previously defined for nitrobenzofuroxans.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.